ScholarWorks@Korea University College of Medicine: Sung, Hwa Jung

Detailed Information

Sung, Hwa Jung (성화정)

Ansan Hospital (Department of Medical Oncology and Hematology, Ansan Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Multiple myeloma:5||multiple myeloma:4||Chemotherapy:4||prognosis:4||Prognosis:3||Gastric cancer:3||bone marrow:3||autologous stem cell transplantation:2||malignancy:2||Hematopoietic stem cell transplantation:2||Acute myeloid leukemia:2||neutropenia:2||Creactive protein:2||Bortezomib:2||Melphalan:2||chemotherapy:2||Treatment outcome:2||Bleeding:1||Body surface area:1||Bone Marrow:1||Breast cancer:1||CD155:1||COVID19:1||CXCR2 human pluripotent stem cells:1||Cancer perception:1||Chest xray:1||Chromosomal microarray:1||Chronic myelogenous leukaemia:1||Chronic myelogenous leukemia:1||Combination chemotherapy:1||Comorbidity:1||Complete cytogenetic response:1||Consolidation chemotherapy:1||Coronavirus:1||Deep vein thrombosis of left thigh:1||Diffuse large B cell lymphoma:1||Diffuse large Bcell lymphoma:1||Docetaxel:1||ESHAP regimen:1||Eculizumab:1||Endovascular management:1||Epirubicin:1||EpsteinBarr virus:1||Febrile neutropenia:1||Galectin3:1||Granulocyte colonystimulating factor:1||Granulysin:1||H1299 and H460 human nonsmall cell lung cancer cell lines:1||Head and neck neoplasms:1||Helicobactor pylori:1||Hematologic malignancy:1||Highdose cytarabine:1||Hodgkin disease:1||Iliac vein compression:1||Imatinib mesylate:1||Immature platelet fraction:1||Immune thrombocytopenia:1||Ingenuity Pathway Analysis (IPA):1||Intensive chemotherapy:1||Interstitial lung disease:1||Korean population:1||Lymphoma:1||Lymphomas:1||Lymphomatoid granulomatosis:1||MLL gene rearrangement:1||Maythurner syndrome:1||Mesenchymal Stem Cells:1||Metastatic breast cancer:1||Modified:1||Monoclonal antibodies:1||NF kappa B:1||NGAL:1||NO donor:1||Nationwide analysis:1||Neuropathy:1||Neutropenia:1||Neutrophillymphocyte ratio:1||NonHodgkin lymphoma:1||Oxaliplatin:1||PVR:1||Paraneoplastic syndrome:1||Paroxysmal nocturnal hemoglobinuria:1||Placenta:1||Platelet count:1||Platelet function analyzer:1||Pneumothorax:1||Positronemission tomography:1||Postprogression survival:1||Posterior leukoencephalopathy syndrome:1||Prednisone:1||Radiomics:1||Response rate:1||Salvage therapy:1||Screening test:1||Second primary cancer:1||Secondary leukemia:1||Sensitive:1||Small cell lung cancer:1||Stemness:1||Surgery:1||Survival:1||Tcell nonHodgkin lymphoma:1||TIGIT:1||Therapyrelated ALL:1||Thrombocytopenia:1||Tomography, Xray computed:1||Treatmentrelated mortality:1||Ulmus davidiana Nakai (UDN):1||University students:1||Vasculitis:1||Young adult:1||acute promyelocytic leukemia:1||adolescent:1||advanced non small cell lung cancer:1||alltrans retinoic acid:1||antifungal prophylaxis:1||biomarker:1||biosimilar:1||bone marrow (BM):1||cancer:1||cancer chemotherapy, nonmyeloablative:1||cancer genetic susceptibility:1||cancer patients:1||capecitabine:1||cereblon:1||cisplatin:1||coronavirus disease 2019:1||cytomegalovirus:1||daily life:1||diffuse large Bcell lymphoma:1||discomfort:1||driving risk:1||early mortality:1||elderly:1||epirubicin:1||esophageal cancer:1||etoposide:1||exosome:1||febrile neutropenia:1||fragile histidine triad (FHIT):1||genomewide association study:1||haplotypes:1||health:1||hematologic:1||hematological:1||hematopoietic toxic effect:1||hypomethylating agent:1||immunomodulatory therapy:1||incidence:1||interruption:1||invasive fungal infection:1||irinotecan:1||leucovorin:1||lung cancer:1||lymphoma:1||medical conditions:1||mobilization:1||more than thirdline:1||neutrophil:1||neutrophil counts:1||neutrophil gelatinaseassociated lipocalin:1||nomograms:1||oral UFT:1||pegylated granulocytecolony stimulating agent:1||perception:1||peripheral blood:1||personal hygiene:1||plasma cells:1||platelet count:1||polygenic risk score:1||polyhexamethylene guanidine phosphate (PHMGp):1||posaconazole:1||prognosis factor:1||radiotherapy:1||recognition:1||redcell aplasia:1||respiratory exposure:1||risk stratification:1||safety:1||single nucleotide polymorphisms:1||stomach neoplasms:1||surgical procedures:1||telomere length:1||thromboembolism:1||tumor immune infiltration:1||vaccine:1||1q abnormality:1||vascular endothelial growth factor:1||5Fluorouracil:1||90K:1||ADI:1||Acute myelogenous leukemia:1||Aggressive NKcell leukemia:1||Aging:1||Albumin:1||Anthracycline:1||Anthracyclines:1||Apoptosis:1||Autophagy:1||Autophagy flux:1||Autophagy inhibitor:1||BCRABL:1||BclXL:1||Bicarbonate:1||

STATISTICS: Total View :12,778,595; Today View :10,306

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE